Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma

Duong‐Quy, Sy; Vu-Minh, Thuc; Hua-Huy, T.; Tang-Thi-Thao, Tram; Le-Quang, Khiet; Tran-Thanh, Dinh; Doan-Thi-Quynh, Nhu; Le-Dong, Nhât-Nam; Craig, Timothy J.; Dinh-Xuan, Anh Tuan

doi:10.2147/jaa.s129047

Cited by 27 publications

(28 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The questionnaires and SPTs about sensitization to 21 different aeroallergens gave us the supporting materials to separate the sample into different groups. The comparisons between the groups showed that the nNO and FeNO levels were significantly higher in AR patients than in normal subjects, which corresponds to results of some other studies 383940. In NAR patients, the nNO levels were not different compared with the norms, while the FeNO levels were significantly higher than in the normal controls.…”

Section: Discussionsupporting

confidence: 87%

Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms

Ren

Zhang

et al. 2019

Allergy Asthma Immunol Res

View full text Add to dashboard Cite

Purpose Nitric oxide (NO) is an important endogenous mediator in both upper and lower respiratory systems. The purpose of the present study was to extract nasal NO (nNO) normal range of Chinese adults and the internal influencing factors. The differences in nNO levels between rhinitis and asymptomatic atopic subjects, and the diagnostic value of nNO in allergic rhinitis (AR) were further investigated. Methods One thousand adults were recruited from the general public. Participants were divided into different subgroups according to the questionnaires and skin prick tests. In all of these subjects, nNO, fractional exhaled NO (FeNO) and nasal airflow resistance were measured. The normal ranges of nNO and FeNO, the differences between subgroups, and the correlations between NO (nNO and FeNO) and other internal factors were analyzed. Results Both nNO and FeNO levels were significantly higher in AR patients than in healthy and asymptomatic atopic subjects. The nNO levels were significantly lower in asymptomatic atopic subjects than in normal adults. FeNO levels were significantly higher in non-AR patients than in the healthy and asymptomatic atopic adults. The cutoff value of nNO for the diagnosis of AR was 117.5 ppb (sensitivity, 50.9%; specificity, 63.9%). The nNO levels were correlated with FeNO levels, total nasal resistance measured at 75Pa, nasal volume within 0–7 cm from the anterior nares (V 0–7cm ) and nasal symptom visual analogue scale (VAS) scores, while the FeNO levels were correlated with age, height, weight, body surface area, nasal volume of V 0–7cm and the nasal symptom VAS score. Conclusions The nNO level can be significantly different between healthy and AR patients and may be significantly correlated with nasal symptoms and nasal patency of rhinitis patients. However, the clinical value of nNO is still in the exploration stage.

show abstract

Section: Discussionsupporting

confidence: 87%

Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms

Ren

Zhang

et al. 2019

Allergy Asthma Immunol Res

View full text Add to dashboard Cite

show abstract

“…The high level of F E NO in asthma has been known for more than 20 years and is used currently as a biomarker for diagnosis and treatment of asthma [ 31 – 34 ]. A high level of F E NO is a good biomarker for response to inhaled corticosteroids in asthmatic patients and is also suggested as a new biomarker recently approved for asthma [ 35 ].…”

Section: Discussionmentioning

confidence: 99%

Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam

Duong‐Quy

Van

Kim

et al. 2018

Canadian Respiratory Journal

Self Cite

View full text Add to dashboard Cite

Introduction Subjects with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) share common features of patients with asthma and COPD. Our study was planned to describe the clinical and functional features of subjects with ACO compared to asthma and COPD patients. Subjects and Methods Study subjects who met the inclusion criteria were classified into three different groups: asthma, COPD, and ACO groups. All study subjects underwent clinical examination and biological and functional testing. They were then followed for 6 months to evaluate the response to conventional treatment. Results From March 2015 to March 2017, 76 asthmatic (mean age: 41 ± 22 years), 74 COPD (59 ± 13 years), and 59 ACO (52 ± 14 years) subjects were included. The percentage of subjects with dyspnea on excretion in the ACO group was higher than that in asthma and COPD groups (P < 0.001 and P < 0.05, resp.). Subjects with COPD and ACO had significant airflow limitation (FEV1) compared to asthma (64 ± 17% and 54 ± 14% versus 80 ± 22%; P < 0.01 and P < 0.01, resp.). The levels of FENO in subjects with asthma and ACO were significantly higher than those in subjects with COPD (46 ± 28 ppb and 34 ± 12 ppb versus 15 ± 8 ppb; P < 0.001 and P < 0.001, resp.). VO2 max and 6MWD were improved in study subjects after 6 months of treatment. Increased CANO and AHI > 15/hour had a significant probability of risk for ACO (OR = 33.2, P < 0.001, and OR = 3.4, P < 0.05, resp.). Conclusion Subjects with ACO share the common clinical and functional characteristics of asthma and COPD but are more likely to have sleep apnea. The majority of patients with ACO have a favourable response to combined treatment.

show abstract

“…The high prevalence of allergic rhinitis in asthma subjects in the present study was similar to another previous study. 17 Braido et al 18 found that approximately 80% of patients with asthma had allergic rhinitis as a comorbidity and increased risk of OSA. As with our previous study, 17 in the present study, there were >80% of asthma patients with allergic rhinitis having nasal congestion.…”

Section: Discussionmentioning

confidence: 99%

“… 17 Braido et al 18 found that approximately 80% of patients with asthma had allergic rhinitis as a comorbidity and increased risk of OSA. As with our previous study, 17 in the present study, there were >80% of asthma patients with allergic rhinitis having nasal congestion. It has been suggested that nasal congestion, a prominent and bothersome symptom of allergic rhinitis, is linked to SDB, including snoring and sleep apnea.…”

Section: Discussionmentioning

confidence: 99%

Study of the clinical and functional characteristics of asthmatic children with obstructive sleep apnea

Nguyen-Hoang¹,

Nguyen-Thi-Dieu²,

Duong‐Quy³

2017

JAA

Self Cite

View full text Add to dashboard Cite

Background and objectiveThe obstructive sleep apnea (OSA) is a common respiratory disorder in children, especially those at preschool and school ages. This study aimed to describe the characteristics of asthmatic children with OSA and the symptoms for a high risk of OSA.Subjects and methodsIt was a prospective and descriptive study. The data of asthmatic children including medical history, clinical examination, blood tests, spirometry, exhaled nitric oxide (NO), and respiratory polygraphy were registered for analyses.ResultsEighty-five asthmatic children with a mean age of 9.5 ± 2.1 years were included. The prevalence of OSA was 65.9% (56/85) in study subjects. The prevalence of severe OSA in children with moderate asthma was significantly higher than intermittent and mild asthma. The percentage of asthmatic children with OSA who had snoring, sleep disturbance, and nocturnal sweats was significantly higher than that of asthmatic children without OSA (48.2% vs 17.2%, 71.4% vs 27.5%, and 55.1% vs 31.0%, respectively). The presence of allergic rhinitis and snoring was associated significantly with a high probability for the presence of OSA.ConclusionChildren with asthma have a risk of OSA. Asthmatic children with suggested symptoms such as snoring or waking up at night should be screened for OSA.

show abstract

Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma

Cited by 27 publications

References 27 publications

Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms

Nasal Nitric Oxide Is Correlated With Nasal Patency and Nasal Symptoms

Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam

Study of the clinical and functional characteristics of asthmatic children with obstructive sleep apnea

Contact Info

Product

Resources

About